We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$599M
AUM Growth
+$99.2M
(+20%)
Cap. Flow
+$49.8M
Cap. Flow
% of AUM
8.31%
Top 10 Holdings %
Top 10 Hldgs %
34.81%
Holding
710
New
83
Increased
162
Reduced
252
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$19.1M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$14.1M |
| 3 |
iShares MSCI Turkey ETF
TUR
|
+$14M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$10.8M |
| 5 |
iShares MSCI Thailand ETF
THD
|
+$9.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$16.7M |
| 2 |
Rogers Communications
RCI
|
+$6.28M |
| 3 |
TechnipFMC
FTI
|
+$5.75M |
| 4 |
PepsiCo
PEP
|
+$4.71M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$3.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 9.52% |
| 2 | Financials | 9.27% |
| 3 | Communication Services | 8.11% |
| 4 | Technology | 7.63% |
| 5 | Materials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Incyte
INCY
$23.5B
| $5.02M | 0.84% |
74,451
+61,035
| +455% | +$4.17M |
|
27
AT&T
T
$165B
| $3.91M | 0.65% |
161,140
-122,494
| -43% | -$3.07M |
|
28
CVS Health
CVS
$137B
| $3.62M | 0.61% |
56,342
+22,154
| +65% | +$1.46M |
|
29
Apple
AAPL
$4.89T
| $3.54M | 0.59% |
76,084
+44,196
| +139% | +$2M |
|
30
Cummins
CMI
$91.7B
| $3.32M | 0.55% |
24,978
+3,091
| +14% | +$463K |
|
31
ROBO Global Robotics & Automation Index ETF
ROBO
$1.9B
| $3.3M | 0.55% |
82,501
| – | – |
|
32
Steel Dynamics
STLD
$35.6B
| $3.24M | 0.54% |
+70,642
| New | +$3.34M |
|
|
33
TechnipFMC
FTI
$30.6B
| $3.22M | 0.54% |
135,674
-241,475
| -64% | -$5.75M |
|
34
IBM
IBM
$202B
| $3.17M | 0.53% |
23,710
+2,797
| +13% | +$390K |
|
35
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $3.11M | 0.52% |
11,451
-62
| -0.5% | -$16.7K |
|
36
Bath & Body Works
BBWI
$4.01B
| $3.01M | 0.5% |
100,879
+80,601
| +397% | +$2.33M |
|
37
Walt Disney
DIS
$165B
| $2.82M | 0.47% |
26,903
-2,093
| -7% | -$214K |
|
38
Western Union
WU
$2.57B
| $2.78M | 0.46% |
136,620
-3,672
| -3% | -$73.1K |
|
|
AGN
39
DELISTED
Allergan plc
AGN
| $2.73M | 0.46% |
+16,374
| New | +$2.63M |
|
40
VanEck Gold Miners ETF
GDX
$23B
| $2.73M | 0.46% |
122,207
+34,982
| +40% | +$784K |
|
41
Honeywell
HON
$77.1B
| $2.72M | 0.45% |
20,936
+4,452
| +27% | +$592K |
|
42
Ford
F
$57.3B
| $2.72M | 0.45% |
245,771
+190,580
| +345% | +$2.18M |
|
43
Verizon
VZ
$194B
| $2.59M | 0.43% |
51,599
-6,575
| -11% | -$318K |
|
44
Avnet
AVT
$7.33B
| $2.54M | 0.42% |
59,134
+6,047
| +11% | +$245K |
|
45
Macy's
M
$6.15B
| $2.52M | 0.42% |
67,243
-22,641
| -25% | -$759K |
|
46
PTC
PTC
$13.7B
| $2.49M | 0.42% |
26,575
-898
| -3% | -$77.7K |
|
47
Elevance Health
ELV
$81.9B
| $2.41M | 0.4% |
+10,138
| New | +$2.35M |
|
48
Omnicom Group
OMC
$22.7B
| $2.41M | 0.4% |
31,616
+1,259
| +4% | +$93K |
|
49
Comcast
CMCSA
$79.1B
| $2.4M | 0.4% |
73,308
+73,305
| +2,443,500% | +$2.39M |
|
|
IPG
50
DELISTED
Interpublic Group of Companies
IPG
| $2.37M | 0.4% |
101,087
-48,152
| -32% | -$1.13M |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2018 Portfolio in Review
As of Q2 2018, Exane Derivatives held 710 positions worth $599M, up 20% from $500M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Exane Derivatives deployed $49.8M of net new capital in Q2 2018, opening 83 new positions and adding to 162 existing holdings. Its largest new stake was UBS Group: 1,172,516 shares worth $18.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 9.5% of assets, down from 9.7% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Freeport-McMoran, an estimated $16.7M trimmed.
- Exane Derivatives's largest Q2 2018 buy was UBS Group: 1,172,516 shares worth $18.1M.
- Exane Derivatives added most to VanEck Russia ETF in Q2 2018, an estimated $14.1M increase.
- Exane Derivatives's biggest Q2 2018 reduction was Freeport-McMoran, cutting an estimated $16.7M.
- Exane Derivatives fully exited Rogers Communications in Q2 2018, selling an estimated $6.28M.
- Exane Derivatives's ten largest holdings make up 35% of its $599M portfolio in Q2 2018.
- Exane Derivatives opened 83 new positions and closed 24 in Q2 2018.
- Exane Derivatives's portfolio value rose 20% quarter-over-quarter to $599M.
Based on Exane Derivatives's 13F filing for Q2 2018, filed 19 Jul 2018.